Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
Feb 07, 2012 Support grows for medical-device community -
Dec 19, 2011 BioAccel launches network to attract bio funding
-
Jul 19, 2011 Cardinal Health opens $11M Phoenix facility
-
Apr 07, 2011 Algae Biosciences Corp. taken public
Share on Twitter
Share on Facebook
Email to a friend
Print Article
From lab to market for PathoGene in Flagstaff
[Source: Arizona Daily Sun] - Northern Arizona University Professor Paul Keim has seen a number of research projects lead to scientific innovations over the last two decades.
He has also watched as many discoveries, despite having practical applications in the real world, have sat idle on laboratory shelves for years, even decades. One of his first discoveries, made more than 18 years ago, is licensed but has never been used commercially.
He has seen how the costs of commercializing a new technology that is unproven in the marketplace can kill a good idea.
For more information: From lab to market for PathoGene in Flagstaff
Quick Links
- NEW: About the Arizona Center for Civic Leadership
- Arizona Biosciences News
- Arizona BioMap
- Roadmap Progress Updates
- Reports & Multimedia
- Timeline: Arizona's Bio Growth
- Arizona Bio Orgs on Twitter
- Arizona BioBasics
- The Biozona Brand
- Newsletter Signup
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.
